Dyrenium (Triamterene) - Summary

DYRENIUM SUMMARY

Dyrenium (triamterene) is a potassium-sparing diuretic.

Dyrenium (triamterene) is indicated in the treatment of edema associated with congestive heart failure, cirrhosis of the liver and the nephrotic syndrome; also in steroid-induced edema, idiopathic edema and edema due to secondary hyperaldosteronism.

Dyrenium may be used alone or with other diuretics either for its added diuretic effect or its potassium-sparing potential. It also promotes increased diuresis when patients prove resistant or only partially responsive to thiazides or other diuretics because of secondary hyperaldosteronism.

See all Dyrenium indications & dosage >>

DYRENIUM NEWS HIGHLIGHTS

Published Studies Related to Dyrenium (Triamterene)

Attenuation of the kaluretic properties of furosemide by triamterene (Dyrenium) in healthy volunteers. [2005.02]

Effect of quinapril and triamterene/hydrochlorothiazide on cardiac and vascular end-organ damage in isolated systolic hypertension. [1998.02]

Pharmacokinetics and pharmacodynamics of triamterene and hydrochlorothiazide and their combination in healthy volunteers. [1997.10]

Felodipine or hydrochlorothiazide/triamterene for treatment of hypertension in the elderly: effects on blood pressure, hypertensive heart disease, metabolic and hormonal parameters. [1996.05]

A study of plasma sodium levels in elderly people taking amiloride or triamterene in combination with hydrochlorothiazide. [1993.10]

more >>

Clinical Trials Related to Dyrenium (Triamterene)

Hemodialysis Without Anticoagulation in Intensive Care Unit [Recruiting]

Diuretics, Hypertension, and Arrhythmias Clinical Trial [Completed]

Renin-Guided Therapeutics in the Management of Untreated, Uncontrolled, or Complicated Hypertension [Completed]

Chronic Hemodialysis Without Systemic Heparinization : a Randomized Study [Recruiting]

more >>